Literature DB >> 7579093

Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate.

F Gaspari1, N Perico, P Ruggenenti, L Mosconi, C S Amuchastegui, E Guerini, E Daina, G Remuzzi.   

Abstract

Renal clearance of inulin is the best available indicator of GFR but cannot be used routinely for clinical purposes and is also difficult to perform for clinical investigation when repeated measurements are required. The aim of this study was to find a reliable alternative to inulin clearance that would allow one to avoid the use of radioactivity and problems related to the continuous infusion of the marker. The plasma clearance of unlabeled iohexol, a nonionic contrast agent, was used. Forty-one patients (creatinine clearance 6 to 160 mL/min per 1.73 m2) underwent simultaneous measurements of renal clearance of inulin and plasma clearance of iohexol. Iohexol was given as a single iv dose, and blood samples were drawn up to 600 min after the administration. Iohexol concentrations (by HPLC) were analyzed by a two-compartment, open-model system. A highly significant correlation between the plasma clearance of iohexol and the renal clearance of inulin over a wide range of GFR values was found. By analyzing the data with a simplified method that uses a one-compartment model corrected with the Bröchner-Mortensen formula, an excellent correlation with the inulin clearance was also observed. When only patients with moderate to severe renal failure were considered, a significant correlation between the two methods was found. A further comparison between GFR determined with iohexol and iopromide, a new low-osmolarity, low-viscosity contrast medium, was also performed in a subgroup of patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7579093     DOI: 10.1681/ASN.V62257

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  80 in total

1.  BioDMET: a physiologically based pharmacokinetic simulation tool for assessing proposed solutions to complex biological problems.

Authors:  John F Graf; Bernhard J Scholz; Maria I Zavodszky
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-12-10       Impact factor: 2.745

Review 2.  How to measure renal function in clinical practice.

Authors:  Jamie Traynor; Robert Mactier; Colin C Geddes; Jonathan G Fox
Journal:  BMJ       Date:  2006-10-07

3.  Lack of effect of DX-619, a novel des-fluoro(6)-quinolone, on glomerular filtration rate measured by serum clearance of cold iohexol.

Authors:  Nenad Sarapa; Prachi Wickremasingha; Nanxiang Ge; Richard Weitzman; Merynda Fuellhart; Cindy Yen; Julia Lloyd-Parks
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

4.  Commonly used estimates of creatinine clearance are inadequate for the very elderly.

Authors:  A Schut; A Anguelov; C Aussel; S Mameri; F Royand; J-P Vincent
Journal:  J Nutr Health Aging       Date:  2009-02       Impact factor: 4.075

5.  Sleep and fatigue symptoms in children and adolescents with CKD: a cross-sectional analysis from the chronic kidney disease in children (CKiD) study.

Authors:  Maria-Eleni Roumelioti; Alicia Wentz; Michael F Schneider; Arlene C Gerson; Stephen Hooper; Mark Benfield; Bradley A Warady; Susan L Furth; Mark L Unruh
Journal:  Am J Kidney Dis       Date:  2010-01-19       Impact factor: 8.860

Review 6.  Measuring glomerular filtration rate in children; can cystatin C replace established methods? A review.

Authors:  Trine Borup Andersen; Anni Eskild-Jensen; Jørgen Frøkiaer; Jens Brøchner-Mortensen
Journal:  Pediatr Nephrol       Date:  2008-10-07       Impact factor: 3.714

7.  Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trial.

Authors:  Piero Ruggenenti; Annalisa Perna; Marcello Tonelli; Giacomina Loriga; Nicola Motterlini; Nadia Rubis; Franca Ledda; Stefano Rota; Andrea Satta; Antonio Granata; Giovanni Battaglia; Francesco Cambareri; Salvatore David; Flavio Gaspari; Nadia Stucchi; Sergio Carminati; Bogdan Ene-Iordache; Paolo Cravedi; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-29       Impact factor: 8.237

8.  Long-term consequences of kidney donation.

Authors:  Hassan N Ibrahim; Robert Foley; LiPing Tan; Tyson Rogers; Robert F Bailey; Hongfei Guo; Cynthia R Gross; Arthur J Matas
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

9.  A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para-aminohippurate clearance in healthy subjects.

Authors:  Justin Koteff; Julie Borland; Shuguang Chen; Ivy Song; Amanda Peppercorn; Takaaki Koshiba; Courtney Cannon; Heather Muster; Stephen C Piscitelli
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

10.  Study Protocol--accurate assessment of kidney function in Indigenous Australians: aims and methods of the eGFR study.

Authors:  Louise J Maple-Brown; Paul D Lawton; Jaquelyne T Hughes; Suresh K Sharma; Graham Rd Jones; Andrew G Ellis; Wendy Hoy; Alan Cass; Richard J Macisaac; Ashim K Sinha; Mark Ab Thomas; Leonard S Piers; Leigh C Ward; Katrina Drabsch; Sianna Panagiotopoulos; Robyn McDermott; Kevin Warr; Sajiv Cherian; Alex Brown; George Jerums; Kerin O'Dea
Journal:  BMC Public Health       Date:  2010-02-19       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.